Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.19
+7.2%
$1.22
$0.84
$2.03
$42.32M0.99135,223 shs154,904 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Medifast, Inc. stock logo
MED
Medifast
$33.55
+0.4%
$37.20
$30.95
$109.52
$364.13M1.14338,986 shs218,380 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
+7.21%+7.21%-0.83%+9.17%-25.63%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Medifast, Inc. stock logo
MED
Medifast
+0.34%+5.22%-6.42%-38.88%-63.05%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
1.6327 of 5 stars
3.50.00.00.00.63.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Medifast, Inc. stock logo
MED
Medifast
3.6029 of 5 stars
3.01.00.01.90.02.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00488.24% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Medifast, Inc. stock logo
MED
Medifast
2.00
Hold$61.0081.85% Upside

Current Analyst Ratings

Latest MED, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
2/21/2024
Medifast, Inc. stock logo
MED
Medifast
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$67.00 ➝ $40.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.76N/AN/A$2.97 per share0.40
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Medifast, Inc. stock logo
MED
Medifast
$1.07B0.34$11.18 per share3.00$18.50 per share1.81

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Medifast, Inc. stock logo
MED
Medifast
$99.42M$9.113.686.71N/A9.27%56.06%33.14%4/29/2024 (Confirmed)

Latest MED, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
4/29/2024N/A
Medifast, Inc. stock logo
MED
Medifast
$0.58N/A-$0.58N/AN/AN/A  
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/20/2024Q4 2023
Medifast, Inc. stock logo
MED
Medifast
$0.99$1.09+$0.10$1.63$184.17 million$191.02 million    
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$0.3630.25%N/AN/A N/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Medifast, Inc. stock logo
MED
Medifast
N/AN/A+3.08%N/A1 Years

Latest MED, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Medifast, Inc. stock logo
MED
Medifast
N/A
2.43
1.84

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Medifast, Inc. stock logo
MED
Medifast
95.51%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Medifast, Inc. stock logo
MED
Medifast
2.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Medifast, Inc. stock logo
MED
Medifast
63410.90 million10.67 millionOptionable

MED, BOLT, CZX, and FCR Headlines

SourceHeadline
Medifast (MED) to Release Quarterly Earnings on MondayMedifast (MED) to Release Quarterly Earnings on Monday
americanbankingnews.com - April 22 at 3:58 AM
Medifasts (MED) Transformation on Track Amid Macro HeadwindsMedifast's (MED) Transformation on Track Amid Macro Headwinds
zacks.com - April 16 at 1:56 PM
Here’s Why Miller Income Strategy Sold Medifast (MED)Here’s Why Miller Income Strategy Sold Medifast (MED)
finance.yahoo.com - April 16 at 9:21 AM
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
businesswire.com - April 15 at 4:05 PM
Medifast (NYSE:MED) investors are sitting on a loss of 85% if they invested three years agoMedifast (NYSE:MED) investors are sitting on a loss of 85% if they invested three years ago
finance.yahoo.com - April 14 at 10:49 AM
Q4 Earnings Highlights: Herbalife (NYSE:HLF) Vs The Rest Of The Personal Care StocksQ4 Earnings Highlights: Herbalife (NYSE:HLF) Vs The Rest Of The Personal Care Stocks
finance.yahoo.com - April 10 at 8:50 AM
Personal Care Stocks Q4 Teardown: Coty (NYSE:COTY) Vs The RestPersonal Care Stocks Q4 Teardown: Coty (NYSE:COTY) Vs The Rest
finance.yahoo.com - April 8 at 7:52 AM
Q4 Earnings Roundup: Nu Skin (NYSE:NUS) And The Rest Of The Personal Care SegmentQ4 Earnings Roundup: Nu Skin (NYSE:NUS) And The Rest Of The Personal Care Segment
finance.yahoo.com - April 5 at 10:34 AM
Spotting Winners: Natures Sunshine (NASDAQ:NATR) And Personal Care Stocks In Q4Spotting Winners: Nature's Sunshine (NASDAQ:NATR) And Personal Care Stocks In Q4
finance.yahoo.com - April 4 at 2:32 PM
Medifast, Inc. (NYSE:MED) Shares Sold by Vanguard Group Inc.Medifast, Inc. (NYSE:MED) Shares Sold by Vanguard Group Inc.
marketbeat.com - April 4 at 4:11 AM
Marfret splashes out on 1,900-teu newbuild ordered by Reederei NordMarfret splashes out on 1,900-teu newbuild ordered by Reederei Nord
tradewindsnews.com - April 3 at 6:06 PM
Personal Care Stocks Q4 Teardown: e.l.f. (NYSE:ELF) Vs The RestPersonal Care Stocks Q4 Teardown: e.l.f. (NYSE:ELF) Vs The Rest
finance.yahoo.com - April 3 at 1:06 PM
Q4 Personal Care Earnings Review: First Prize Goes to The Honest Company (NASDAQ:HNST)Q4 Personal Care Earnings Review: First Prize Goes to The Honest Company (NASDAQ:HNST)
finance.yahoo.com - April 2 at 8:11 AM
(MED) - Analyzing Medifasts Short Interest(MED) - Analyzing Medifast's Short Interest
benzinga.com - April 1 at 5:09 PM
Optavia Diet Review 2024: Does This Program Really Work for Weight Loss?Optavia Diet Review 2024: Does This Program Really Work for Weight Loss?
msn.com - March 28 at 8:42 AM
Q4 Rundown: BeautyHealth (NASDAQ:SKIN) Vs Other Personal Care StocksQ4 Rundown: BeautyHealth (NASDAQ:SKIN) Vs Other Personal Care Stocks
finance.yahoo.com - March 28 at 8:42 AM
American Century Companies Inc. Acquires 49,605 Shares of Medifast, Inc. (NYSE:MED)American Century Companies Inc. Acquires 49,605 Shares of Medifast, Inc. (NYSE:MED)
marketbeat.com - March 28 at 4:06 AM
Pacer Advisors Inc. Buys 201,752 Shares of Medifast, Inc. (NYSE:MED)Pacer Advisors Inc. Buys 201,752 Shares of Medifast, Inc. (NYSE:MED)
marketbeat.com - March 26 at 7:48 AM
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 21 at 6:39 PM
Medifast: Cheap Valuation, Uncertain FutureMedifast: Cheap Valuation, Uncertain Future
seekingalpha.com - March 20 at 12:06 PM
LifeMD Shares Come Back to Life on GLP-1 Business Growth  (MED)LifeMD Shares Come Back to Life on GLP-1 Business Growth (MED)
marketbeat.com - March 19 at 6:05 AM
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
zacks.com - March 18 at 6:16 AM
MED Apr 2024 20.000 putMED Apr 2024 20.000 put
finance.yahoo.com - March 16 at 1:09 AM
Should You Think About Buying Medifast, Inc. (NYSE:MED) Now?Should You Think About Buying Medifast, Inc. (NYSE:MED) Now?
finance.yahoo.com - March 14 at 2:01 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Medifast logo

Medifast

NYSE:MED
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.